These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 920775)

  • 1. Hemoglobin F levels do not change during the painful crisis of sickle cell anemia.
    Steinberg MH; Adams JG
    Am J Obstet Gynecol; 1977 Nov; 129(6):712-3. PubMed ID: 920775
    [No Abstract]   [Full Text] [Related]  

  • 2. Developing treatment for sickle cell disease.
    Steinberg MH; Brugnara C
    Expert Opin Investig Drugs; 2002 May; 11(5):645-59. PubMed ID: 11996646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor hemoglobins in sickle-cell heterozygotes and homozygotes with and without diabetes.
    Abraham EC; Stallings M; Cameron BF; Huisman TH
    Biochim Biophys Acta; 1980 Sep; 625(1):109-17. PubMed ID: 6158340
    [No Abstract]   [Full Text] [Related]  

  • 4. Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.
    Poillon WN; Kim BC; Rodgers GP; Noguchi CT; Schechter AN
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5039-43. PubMed ID: 7685112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle cell disease severity: an introduction.
    Pace BS; Goodman SR
    Exp Biol Med (Maywood); 2016 Apr; 241(7):677-8. PubMed ID: 27190296
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxyurea, sickle cell disease and renal transplantation.
    Allen A; Scoble J; Snowden S; Hambley H; Bellingham A
    Nephron; 1997; 75(1):106-7. PubMed ID: 9031282
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluctuation of fetal hemoglobin in sickle-cell anemia.
    Morrison JC; Whybrew WD; Bucovaz ET; Wiser WL
    Am J Obstet Gynecol; 1976 Aug; 125(8):1085-8. PubMed ID: 952305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of sickle cell anaemia in Arabs: review of cases with various amounts of fetal haemoglobin.
    Kamel K
    J Med Genet; 1979 Dec; 16(6):428-30. PubMed ID: 94097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human fetal hemoglobin: significance in disease.
    Bertles JF
    Ann N Y Acad Sci; 1974 Nov; 241(0):638-52. PubMed ID: 4611309
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Hemoglobin F and sickle-cell anemia.
    Strauss RG
    Am J Clin Pathol; 1975 Feb; 63(2):289. PubMed ID: 1115040
    [No Abstract]   [Full Text] [Related]  

  • 12. Sickle cell-beta 0-thalassaemia in Saudi Arabia.
    el-Hazmi MA; Al-Swailem AR
    Hum Hered; 1987; 37(4):211-6. PubMed ID: 2443440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell anemia as a multigenetic disease: new insights into the mechanism of painful crisis.
    Nagel RL; Fabry ME
    Prog Clin Biol Res; 1984; 165():93-102. PubMed ID: 6209732
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythrocyte I-i antigens: distribution in normal and sickle erythrocytes and relationship of i antigenicity to hemoglobin F cell content.
    Maniatis A; Bertles JF
    Prog Clin Biol Res; 1978; 20():159-71. PubMed ID: 652815
    [No Abstract]   [Full Text] [Related]  

  • 15. High prevalence of individuals with low concentration of fetal hemoglobin in F-cells in sickle cell anemia in Tanzania.
    Urio F; Lyimo M; Mtatiro SN; Cox SE; Mmbando BP; Makani J
    Am J Hematol; 2016 Aug; 91(8):E323-4. PubMed ID: 27085091
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal hemoglobin F levels may have an adverse effect on neonatal birth weight in pregnancies with sickle cell disease.
    Anyaegbunam A; Billett HH; Langer O; Brustman L; Berger C; Wyse L; Nagel RL; Merkatz IR
    Am J Obstet Gynecol; 1989 Sep; 161(3):654-6. PubMed ID: 2476930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The X chromosome, fetal hemoglobin and sickle cell anemia].
    Labie D; Elion J; Girot R
    Nouv Rev Fr Hematol (1978); 1991; 33(2):139-41. PubMed ID: 1722574
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating cell-free DNA in sickle cell disease: is it a potentially useful biomarker?
    Al-Humood S; Zueriq R; Al-Faris L; Marouf R; Al-Mulla F
    Arch Pathol Lab Med; 2014 May; 138(5):678-83. PubMed ID: 24786126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
    Okam MM; Ebert BL
    Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].
    Nkashama GM; Wakamb GK; Mulangu AM; Nkashama GM; Kupa BK; Numbi OL
    Pan Afr Med J; 2015; 21():124. PubMed ID: 26327961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.